Evidence of Anti-Fibrotic Activity for Obefazimod
Obefazimod is an oral, first-in-class, small-molecule drug candidate that selectively enhances microRNA-124 (miR-124), a natural anti-inflammatory agent.
This is more immunomodulation than suppression.
Drug is killing is in the UC data, Crohns data is lagging but promising so far.
Interesting stuff













